Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00157690Phase 4Completed
Phase 4, randomised, double-blind trial in osteoporosis and osteopenia comparing Alendronate with Placebo (2 arms). Primary endpoint: Lumbar Spine Bone Mineral Density at 12 months. Started Dec 2003; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00157690.